Alisol A 23-acetateCAS# 19865-75-9 |
- Alisol E 23-acetate
Catalog No.:BCN3459
CAS No.:155301-58-9
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 19865-75-9 | SDF | Download SDF |
PubChem ID | 70690607 | Appearance | White powder |
Formula | C32H52O6 | M.Wt | 532.75 |
Type of Compound | Triterpenoids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | [(3R,4S,6R)-2,3-dihydroxy-6-[(5R,8S,9S,10S,11S,14R)-11-hydroxy-4,4,8,10,14-pentamethyl-3-oxo-1,2,5,6,7,9,11,12,15,16-decahydrocyclopenta[a]phenanthren-17-yl]-2-methylheptan-4-yl] acetate | ||
SMILES | CC(CC(C(C(C)(C)O)O)OC(=O)C)C1=C2CC(C3C4(CCC(=O)C(C4CCC3(C2(CC1)C)C)(C)C)C)O | ||
Standard InChIKey | KRZLECBBHPYBFK-JSWHPQHOSA-N | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 1. Alisol A 23-acetate may possess therapeutic effects through their modulation of AR, PR, and GR pathways. |
Targets | Androgen Receptor |
Alisol A 23-acetate Dilution Calculator
Alisol A 23-acetate Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 1.8771 mL | 9.3853 mL | 18.7705 mL | 37.5411 mL | 46.9263 mL |
5 mM | 0.3754 mL | 1.8771 mL | 3.7541 mL | 7.5082 mL | 9.3853 mL |
10 mM | 0.1877 mL | 0.9385 mL | 1.8771 mL | 3.7541 mL | 4.6926 mL |
50 mM | 0.0375 mL | 0.1877 mL | 0.3754 mL | 0.7508 mL | 0.9385 mL |
100 mM | 0.0188 mL | 0.0939 mL | 0.1877 mL | 0.3754 mL | 0.4693 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Tranylcypromine hydrochloride
Catalog No.:BCC7791
CAS No.:1986-47-6
- Fmoc-Ser(tBu)-ol
Catalog No.:BCC2578
CAS No.:198561-87-4
- Fmoc-HoTyr-OH.DCHA
Catalog No.:BCC3246
CAS No.:198560-10-0
- Fmoc-Asparaginol(Trt)
Catalog No.:BCC3042
CAS No.:198543-08-7
- 9,10-Anthracenedione
Catalog No.:BCN3469
CAS No.:19852-76-7
- Bazedoxifene acetate
Catalog No.:BCC1412
CAS No.:198481-33-3
- Bazedoxifene
Catalog No.:BCC1411
CAS No.:198481-32-2
- Bazedoxifene HCl
Catalog No.:BCC4492
CAS No.:198480-56-7
- Boc-Pen(pMeBzl)-OH.DCHA
Catalog No.:BCC2623
CAS No.:198474-61-2
- Parecoxib Sodium
Catalog No.:BCC4248
CAS No.:198470-85-8
- Parecoxib
Catalog No.:BCC4041
CAS No.:198470-84-7
- Boc-D-Pen(pMeBzl)-OH.DCHA
Catalog No.:BCC3308
CAS No.:198470-36-9
- Alisol B acetate
Catalog No.:BCN2304
CAS No.:19865-76-0
- Cabralealactone
Catalog No.:BCN4870
CAS No.:19865-87-3
- MLCK inhibitor peptide
Catalog No.:BCC5852
CAS No.:198694-74-5
- 1,3-Dicaffeoylquinic acid
Catalog No.:BCN2972
CAS No.:19870-46-3
- Bavachinin
Catalog No.:BCN4871
CAS No.:19879-30-2
- Bavachin
Catalog No.:BCN4872
CAS No.:19879-32-4
- Windorphen
Catalog No.:BCC6486
CAS No.:19881-70-0
- Merimepodib
Catalog No.:BCC4128
CAS No.:198821-22-6
- (7R)-Methoxy-8-epi-matairesinol
Catalog No.:BCN7582
CAS No.:198827-23-5
- Z-D-Tyr(tBu)-OH.DCHA
Catalog No.:BCC2744
CAS No.:198828-72-7
- H-D-Phg-OMe.HCl
Catalog No.:BCC3314
CAS No.:19883-41-1
- H-Phe(2-F)-OH
Catalog No.:BCC3222
CAS No.:19883-78-4
Triterpenes from Alisma orientalis act as androgen receptor agonists, progesterone receptor antagonists, and glucocorticoid receptor antagonists.[Pubmed:24915879]
Bioorg Med Chem Lett. 2014 Aug 1;24(15):3626-32.
Alisma orientalis, a well-known traditional medicine, exerts numerous pharmacological effects including anti-diabetes, anti-hepatitis, and anti-diuretics but its bioactivity is not fully clear. Androgen receptor (AR), progesterone receptor (PR), and glucocorticoid receptor (GR) are three members of nuclear receptor superfamily that has been widely targeted for developing treatments for essential diseases including prostate cancer and breast cancer. In this study, two triterpenes, alisol M 23-acetate and Alisol A 23-acetate from Alisma orientalis were determined whether they may act as androgen receptor (AR), progesterone receptor (PR), or glucocorticoid receptor (GR) modulators. Indeed, in the transient transfection reporter assays, alisol M 23-acetate and Alisol A 23-acetate transactivated AR in dose-dependent manner, while they transrepressed the transactivation effects exerted by agonist-activated PR and GR. Through molecular modeling docking studies, they were shown to respectively interact with AR, PR, or GR ligand binding pocket fairly well. All these results indicate that alisol M 23-acetate and Alisol A 23-acetate from Alisma orientalis might possess therapeutic effects through their modulation of AR, PR, and GR pathways.